Cargando…
Ablation of Matrix Metalloproteinase-9 Prevents Cardiomyocytes Contractile Dysfunction in Diabetics
Elevated expression and activity of matrix metalloproteinase-9 (MMP9) and decreased contractility of cardiomyocytes are documented in diabetic hearts. However, it is unclear whether MMP is involved in the regulation of contractility of cardiomyocytes in diabetic hearts. In the present study, we test...
Autores principales: | Prathipati, Priyanka, Metreveli, Naira, Nandi, Shyam Sundar, Tyagi, Suresh C., Mishra, Paras K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791405/ https://www.ncbi.nlm.nih.gov/pubmed/27014091 http://dx.doi.org/10.3389/fphys.2016.00093 |
Ejemplares similares
-
Matrix metalloproteinase inhibition mitigates renovascular remodeling in salt-sensitive hypertension
por: Pushpakumar, Sathnur B, et al.
Publicado: (2013) -
MiR-133a Mimic Alleviates T1DM-Induced Systolic Dysfunction in Akita: An MRI-Based Study
por: Nandi, Shyam Sundar, et al.
Publicado: (2018) -
A N-terminal truncated intracellular isoform of matrix metalloproteinase-2 impairs contractility of mouse myocardium
por: Lovett, David H., et al.
Publicado: (2014) -
H(2)S and homocysteine control a novel feedback regulation of cystathionine beta synthase and cystathionine gamma lyase in cardiomyocytes
por: Nandi, Shyam Sundar, et al.
Publicado: (2017) -
Approaches to High-Throughput Analysis of Cardiomyocyte Contractility
por: Wright, Peter T., et al.
Publicado: (2020)